Literature DB >> 12707271

Transcriptional inhibition of interleukin-8 expression in tumor necrosis factor-tolerant cells: evidence for involvement of C/EBP beta.

Marion Weber1, Carmen Sydlik, Martina Quirling, Caroline Nothdurfter, Andreas Zwergal, Peter Heiss, Susanne Bell, Dieter Neumeier, H W Loms Ziegler-Heitbrock, Korbinian Brand.   

Abstract

There is some evidence that the potent cytokine tumor necrosis factor (TNF) is able to induce tolerance after repeated stimulation of cells. To investigate the molecular mechanisms mediating this phenomenon, the expression of interleukin-8 (IL-8), which is regulated by transcription factors NF-kappaB and C/EBPbeta, was monitored under TNF tolerance conditions. Pretreatment of monocytic cells for 72 h with low TNF doses inhibited TNF-induced (restimulation with a high dose) IL-8 promoter-dependent transcription as well as IL-8 production. Under these conditions neither activation of NF-kappaB nor IkappaB proteolysis was affected after TNF re-stimulation, albeit a slightly reduced IkappaB-alpha level was found in the TNF pretreated but not re-stimulated sample. Remarkably, in tolerant cells an increased binding of C/EBPbeta to its IL-8 promoter-specific DNA motif as well as an elevated association of C/EBPbeta protein with p65-containing NF-kappaB complexes was observed. Finally, overexpression of C/EBPbeta, but not p65 or Oct-1, markedly prevented TNF-induced IL-8 promoter-dependent transcription. Taken together, these data indicate that the expression of IL-8 is inhibited at the transcriptional level in TNF-tolerant cells and C/EBPbeta is involved under these conditions in mediating the negative-regulatory effects, a mechanism that may play a role in inflammatory processes such as sepsis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707271     DOI: 10.1074/jbc.M211646200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.

Authors:  Thararat Nualsanit; Pleumchitt Rojanapanthu; Wandee Gritsanapan; Seong-Ho Lee; Darunee Lawson; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2011-08-17       Impact factor: 6.048

2.  Improved antimicrobial host defense in mice following poly-(1,6)-β-D-glucopyranosyl-(1,3)-β-D-glucopyranose glucan treatment by a gender-dependent immune mechanism.

Authors:  Courtni T Newsome; Estefany Flores; Alfred Ayala; Stephen Gregory; Jonathan S Reichner
Journal:  Clin Vaccine Immunol       Date:  2011-10-05

3.  Heterogeneity in lipopolysaccharide responsiveness of endothelial cells identified by gene expression profiling: role of transcription factors.

Authors:  G C Beck; N Rafat; P Brinkkoetter; C Hanusch; J Schulte; M Haak; K van Ackern; F J van der Woude; B A Yard
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

4.  Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.

Authors:  Katrin Noack; Nisintha Mahendrarajah; Dorle Hennig; Luisa Schmidt; Florian Grebien; Dagmar Hildebrand; Markus Christmann; Bernd Kaina; Andreas Sellmer; Siavosh Mahboobi; Katharina Kubatzky; Thorsten Heinzel; Oliver H Krämer
Journal:  Arch Toxicol       Date:  2016-11-02       Impact factor: 5.153

5.  CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.

Authors:  Romina Gutsch; Judith D Kandemir; Daniel Pietsch; Christian Cappello; Johann Meyer; Kathrin Simanowski; René Huber; Korbinian Brand
Journal:  J Biol Chem       Date:  2011-05-10       Impact factor: 5.157

Review 6.  TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms.

Authors:  René Huber; Rolf Bikker; Bastian Welz; Martin Christmann; Korbinian Brand
Journal:  J Immunol Res       Date:  2017-11-08       Impact factor: 4.818

Review 7.  GSK3: A Kinase Balancing Promotion and Resolution of Inflammation.

Authors:  Leonie Hoffmeister; Mareike Diekmann; Korbinian Brand; René Huber
Journal:  Cells       Date:  2020-03-28       Impact factor: 6.600

8.  Model-based understanding of single-cell CRISPR screening.

Authors:  Bin Duan; Chi Zhou; Chengyu Zhu; Yifei Yu; Gaoyang Li; Shihua Zhang; Chao Zhang; Xiangyun Ye; Hanhui Ma; Shen Qu; Zhiyuan Zhang; Ping Wang; Shuyang Sun; Qi Liu
Journal:  Nat Commun       Date:  2019-05-20       Impact factor: 14.919

9.  Systemic lupus erythematosus variants modulate the function of an enhancer upstream of TNFAIP3.

Authors:  Satish Pasula; Jaanam Gopalakrishnan; Yao Fu; Kandice L Tessneer; Mandi M Wiley; Richard C Pelikan; Jennifer A Kelly; Patrick M Gaffney
Journal:  Front Genet       Date:  2022-09-19       Impact factor: 4.772

10.  Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1.

Authors:  Valerie Albrecht; Thomas P J Hofer; Brian Foxwell; Marion Frankenberger; Loems Ziegler-Heitbrock
Journal:  BMC Immunol       Date:  2008-11-24       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.